Optimum lesion set and predictors of outcome in persistent atrial fibrillation ablation: a meta-regression analysis.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 Aug 2019
Historique:
received: 14 11 2018
accepted: 27 03 2019
pubmed: 10 5 2019
medline: 1 12 2020
entrez: 10 5 2019
Statut: ppublish

Résumé

Ablation of persistent atrial fibrillation (PsAF) has been performed by many techniques with varying success rates. This may be due to ablation techniques, patient demographics, comorbidities, and trial design. We conducted a meta-regression of studies of PsAF ablation to elucidate the factors affecting atrial fibrillation (AF) recurrence. Databases were searched for prospective studies of PsAF ablation. A meta-regression was performed. Fifty-eight studies (6767 patients) were included. Complex fractionated atrial electrogram (CFAE) ablation reduced freedom from AF by 8.9% [95% confidence interval (CI) -15 to -2.3, P = 0.009). Left atrial appendage [LAA isolation (three study arms)] increased freedom from AF by 39.5% (95% CI 9.1-78.4, P = 0.008). Posterior wall isolation (PWI) (eight study arms) increased freedom from AF by 19.4% (95% CI 3.3-38.1, P = 0.017). Linear ablation or ganglionated plexi ablation resulted in no significant effect on freedom from AF. More extensive ablation increased intraprocedural AF termination; however, intraprocedural AF termination was not associated with improved outcomes. Increased left atrial diameter was associated with a reduction in freedom from AF by 4% (95% CI -6.8% to -1.1%, P = 0.007) for every 1 mm increase in diameter. Linear ablation, PWI, and CFAE ablation improves intraprocedural AF termination, but such termination does not predict better long-term outcomes. Study arms including PWI or LAA isolation in the lesion set were associated with improved outcomes in terms of freedom from AF; however, further randomized trials are required before these can be routinely recommended. Left atrial size is the most important marker of AF chronicity influencing outcomes.

Identifiants

pubmed: 31071213
pii: 5487276
doi: 10.1093/europace/euz108
pmc: PMC6680367
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

1176-1184

Subventions

Organisme : British Heart Foundation
ID : FS/14/27/30752
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/10/002/28189
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/11/92/29122
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/16/17/32069
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/16/3/32175
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Références

Ann Thorac Surg. 1997 Apr;63(4):1070-5
pubmed: 9124907
J Cardiovasc Electrophysiol. 2015 Jun;26(6):608-14
pubmed: 25772569
Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1017-29
pubmed: 26082515
N Engl J Med. 2015 May 7;372(19):1812-22
pubmed: 25946280
Circ Arrhythm Electrophysiol. 2009 Feb;2(1):35-40
pubmed: 19808442
Circ Arrhythm Electrophysiol. 2012 Oct;5(5):968-77
pubmed: 22972873
Circulation. 2010 Jul 13;122(2):109-18
pubmed: 20606120
Int J Cardiol. 2015 Feb 15;181:277-83
pubmed: 25535691
Circ Arrhythm Electrophysiol. 2015 Aug;8(4):963-71
pubmed: 26286305
Circ Arrhythm Electrophysiol. 2016 Jul;9(7):
pubmed: 27406602
Heart Rhythm. 2011 Jul;8(7):994-1000
pubmed: 21397045
PLoS One. 2016 Oct 20;11(10):e0164989
pubmed: 27764185
Europace. 2016 Mar;18(3):359-67
pubmed: 26559915
Curr Cardiol Rev. 2017;13(3):199-208
pubmed: 28124593
Europace. 2018 Nov 1;20(FI_3):f366-f376
pubmed: 29267853
Circ Arrhythm Electrophysiol. 2014 Oct;7(5):841-52
pubmed: 25132078
Circ Arrhythm Electrophysiol. 2010 Jun;3(3):243-8
pubmed: 20339034
J Am Coll Cardiol. 2016 Nov 1;68(18):1929-1940
pubmed: 27788847
Cochrane Database Syst Rev. 2016 Nov 22;11:CD012088
pubmed: 27871122

Auteurs

Arunashis Sau (A)

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.

Sayed Al-Aidarous (S)

Department of Cardiology, Royal Brompton and Harefield NHS Foundation Trust, London, UK.

James Howard (J)

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.
Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Joseph Shalhoub (J)

Department of Surgery and Cancer, Imperial College London, London, UK.

Afzal Sohaib (A)

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.

Matthew Shun-Shin (M)

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.
Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Paul G Novak (PG)

Department of Cardiology, Royal Jubilee Hospital, Victoria, 1952 Bay St, British Columbia, Canada.

Rick Leather (R)

Department of Cardiology, Royal Jubilee Hospital, Victoria, 1952 Bay St, British Columbia, Canada.

Laurence D Sterns (LD)

Department of Cardiology, Royal Jubilee Hospital, Victoria, 1952 Bay St, British Columbia, Canada.

Christopher Lane (C)

Department of Cardiology, Royal Jubilee Hospital, Victoria, 1952 Bay St, British Columbia, Canada.

Prapa Kanagaratnam (P)

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.
Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Nicholas S Peters (NS)

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.
Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Darrel P Francis (DP)

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.
Department of Cardiology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Markus B Sikkel (MB)

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.
Department of Cardiology, Royal Jubilee Hospital, Victoria, 1952 Bay St, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH